Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Ganser

Showing results (21-30 of 378) with videos related to

Pageof 38
Sort By:
Scandinavian Journal of Haematology|October 1, 1985
Megakaryocytic differentiation capacity of human pluripotent bone marrow progenitor cells CFU-GEMM in vitro after cryopreservationA Ganser, D Hoelzer
Annals of Hematology|October 24, 2001
Evolving treatment options of myelodysplastic syndromesW Verbeek, A Ganser
Haematology and Blood Transfusion|January 1, 1985
Differentiation capacity of null-AL(L) cells in cultureA Ganser, D Hoelzer
Zentralblatt Fur Gynakologie|January 1, 1997
[Current status of clinical indications for hematopoietic growth factors after chemo-/radiotherapy in gynecology]M Karthaus, A Ganser
Der Internist|October 27, 2004
[Bone marrow transplantation. Indications, chances and perspectives]B Hertenstein, A Ganser
Current Opinion in Oncology|July 1, 1996
Clinical use of hematopoietic growth factorsA Ganser, M Karthaus
Current Opinion in Hematology|May 1, 1997
Use of hematopoietic growth factors in the treatment of acute myelogenous leukemiaA Ganser, G Heil
Leukemia & Lymphoma|May 7, 1998
Clinical use of hematopoietic growth factors in the myelodysplastic syndromesA Ganser, M Karthaus
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|November 21, 2007
Myelodysplastic syndromes: a guide to treatment with epoetin and colony-stimulating factorsR G Geissler, A Ganser
The New England Journal of Medicine|May 16, 1996
P-glycoprotein and multidrug resistanceS Duensing, A Ganser, J Atzpodien
Pageof 38

Showing results (21-30 of 378) with videos related to

Sort By:
Pageof 38
Scandinavian Journal of Haematology|October 1, 1985
Megakaryocytic differentiation capacity of human pluripotent bone marrow progenitor cells CFU-GEMM in vitro after cryopreservationA Ganser, D Hoelzer
Annals of Hematology|October 24, 2001
Evolving treatment options of myelodysplastic syndromesW Verbeek, A Ganser
Haematology and Blood Transfusion|January 1, 1985
Differentiation capacity of null-AL(L) cells in cultureA Ganser, D Hoelzer
Zentralblatt Fur Gynakologie|January 1, 1997
[Current status of clinical indications for hematopoietic growth factors after chemo-/radiotherapy in gynecology]M Karthaus, A Ganser
Der Internist|October 27, 2004
[Bone marrow transplantation. Indications, chances and perspectives]B Hertenstein, A Ganser
Current Opinion in Oncology|July 1, 1996
Clinical use of hematopoietic growth factorsA Ganser, M Karthaus
Current Opinion in Hematology|May 1, 1997
Use of hematopoietic growth factors in the treatment of acute myelogenous leukemiaA Ganser, G Heil
Leukemia & Lymphoma|May 7, 1998
Clinical use of hematopoietic growth factors in the myelodysplastic syndromesA Ganser, M Karthaus
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|November 21, 2007
Myelodysplastic syndromes: a guide to treatment with epoetin and colony-stimulating factorsR G Geissler, A Ganser
The New England Journal of Medicine|May 16, 1996
P-glycoprotein and multidrug resistanceS Duensing, A Ganser, J Atzpodien
Pageof 38